Eledon Pharmaceuticals Inc (ELDN)

Jun 13, 2026

ELDN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 13, 2026

Jun 12, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 12, 2026

Jun 10, 2026

Eledon Pharmaceuticals (ELDN) Announces Updated Results From Investigator-Initiated Trial Evaluating tegoprubart - Insider Monkey

Jun 10, 2026

Jun 10, 2026

10 Hot Biotech Stocks Under $5 to Buy - Insider Monkey

Jun 10, 2026

Jun 08, 2026

Eledon trial shows all 12 diabetes patients achieve insulin independence By Investing.com - Investing.com Australia

Jun 08, 2026

Jun 08, 2026

Eledon Pharmaceuticals (ELDN) Reports Promising Results for Tego - GuruFocus

Jun 08, 2026

Jun 08, 2026

Midday Stock Roundup: Eledon Up 4% on T1D Trial Results - Orange County Business Journal

Jun 08, 2026

Jun 08, 2026

Eledon Pharmaceuticals stock surges on diabetes trial results By Investing.com - Investing.com South Africa

Jun 08, 2026

Jun 08, 2026

Eledon Pharmaceuticals stock surges on diabetes trial results - Investing.com

Jun 08, 2026

Jun 08, 2026

Eledon Pharmaceuticals (ELDN) Reports Promising Results for Tegoprubart in T1D Trials - GuruFocus

Jun 08, 2026

Jun 08, 2026

Eledon trial shows all 12 diabetes patients achieve insulin independence - Investing.com

Jun 08, 2026

Jun 08, 2026

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine - The Manila Times

Jun 08, 2026

Jun 05, 2026

Eledon Pharmaceuticals Inc (ELDN) Stock Price, Quote, News & History - Benzinga

Jun 05, 2026

Jun 04, 2026

Eledon presents updated trial data on tegoprubart for type 1 diabetes at ADA 2026. - Pluang

Jun 04, 2026

Jun 04, 2026

Eledon trial results to be presented at diabetes conference By Investing.com - Investing.com South Africa

Jun 04, 2026

Jun 04, 2026

Eledon trial results to be presented at diabetes conference - Investing.com

Jun 04, 2026

Jun 04, 2026

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions - The Manila Times

Jun 04, 2026

Jun 04, 2026

Type 1 diabetes islet transplant brings updated tegoprubart data to ADA - Stock Titan

Jun 04, 2026

Jun 02, 2026

Eledon Pharmaceuticals, Inc. - MLQ.ai

Jun 02, 2026

May 29, 2026

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

May 29, 2026

May 27, 2026

Breakthrough in Diabetes Treatment with ELDN's New Drug Submissi - GuruFocus

May 27, 2026

May 27, 2026

EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND SubmissionEledon Pha - Benzinga

May 27, 2026

May 27, 2026

Stem cell therapy targeting a potential type 1 diabetes cure nears trials - Stock Titan

May 27, 2026

May 24, 2026

ELDN Technical Analysis & Stock Price Forecast - Intellectia AI

May 24, 2026

May 21, 2026

Eledon to present kidney transplant trial data at conference - Investing.com UK

May 21, 2026

May 21, 2026

Eledon to present kidney transplant trial data at conference By Investing.com - Investing.com Australia

May 21, 2026

May 20, 2026

Eledon to present new Phase 2 data on tegoprubart for kidney transplant rejection at June congress - Pluang

May 20, 2026

May 20, 2026

New kidney transplant rejection data from tegoprubart at ATC - Stock Titan

May 20, 2026

May 20, 2026

Eledon Pharmaceuticals to Present New Long-Term Data from - GlobeNewswire

May 20, 2026

May 17, 2026

LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $6 - Moomoo

May 17, 2026

May 17, 2026

TradingKey - TradingKey

May 17, 2026

May 15, 2026

BVF Group Discloses Convertible Stakes in Eledon (ELDN) — 9.99% Blockers - Stock Titan

May 15, 2026

May 14, 2026

Eledon Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $8.2, Implies 111% Upside - TradingView

May 14, 2026

May 14, 2026

LifeSci Capital Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Raises Target Price to $6 - Moomoo

May 14, 2026

May 14, 2026

Eledon Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times

May 14, 2026

May 13, 2026

How Should Investors Value Eledon Pharmaceuticals (ELDN) After Q - GuruFocus

May 13, 2026

May 13, 2026

Eledon (ELDN) Advances in Tegoprubart Development with Key Miles - GuruFocus

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals (ELDN) Reports Q1 Loss, Cash Reserves Dec - GuruFocus

May 13, 2026

May 13, 2026

Eledon Pharma Expects Cash, Cash Equivalents and Short-Term Investments to Fund Ops Into 2Q 2027 >ELDN - Moomoo

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals 1Q Loss/Shr 33c >ELDN - Moomoo

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals reports Q1 EPS (33c), consensus (23c) - TipRanks

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals Q1 net loss widens on warrant liability loss - TradingView

May 13, 2026

May 13, 2026

Eledon Pharmaceuticals (ELDN) deepens Q1 2026 loss as R&D rises but cash totals $111M - Stock Titan

May 13, 2026

May 13, 2026

[8-K] Eledon Pharmaceuticals, Inc. Reports Material Event - Stock Titan

May 13, 2026